Optimizing early phase trials key to success of novel cytotoxics & targeted therapies 6 June 2012 / By katie barden / Antibodies, Clinical Trials / 0 comments
Roche speak at Exploratory Clinical Development World #ecdworld 24 May 2012 / By katie barden / Clinical Trials / 0 comments
Patients with nothing to lose conducting their own clinical trials? 14 May 2012 / By katie barden / Clinical Trials / 0 comments
2 weeks till Exploratory Clinical Development World Europe takes place 11 May 2012 / By katie barden / Clinical Trials / 0 comments
Will there be a vaccine for Salmonella soon? #pharma 2 May 2012 / By katie barden / Clinical Trials / 0 comments
Phil Birch, Corporate Brand Manager, Aptiv Solutions discusses challenges in #clinical development 25 April 2012 / By katie barden / Clinical Trials / 0 comments
Iris pharma & RxGen announce strategic alliance 24 April 2012 / By katie barden / Clinical Trials / 0 comments
ReXceptor looking to raise funding for phase I #clinicaltrial 17 April 2012 / By katie barden / Clinical Trials / 0 comments
Nuron Biotech has licensed a gene-based amyloid beta 42 (Aβ42) #vaccine 10 April 2012 / By katie barden / Antibodies, Clinical Trials / 0 comments
